Valuation: IXICO plc

Market Cap 16.97M 22.48M 20.08M 18.72M 31.94M 2.13B 32.19M 224M 87.78M 1.11B 84.43M 82.58M 3.56B P/E 2026 *
-5.54x
P/E 2027 * -5.96x
Enterprise Value 6.77M 8.97M 8.01M 7.47M 12.74M 851M 12.84M 89.46M 35.02M 443M 33.68M 32.94M 1.42B EV / Sales 2026 *
0.85x
EV / Sales 2027 * 1.21x
Free-Float
89.57%
Yield 2026 *
-
Yield 2027 * -
1 day+6.45%
1 week+3.12%
Current month+10.00%
1 month+10.00%
6 months+11.86%
Current year-29.79%
1 week 7.46
Extreme 7.455
8.5
1 month 7
Extreme 7
8.5
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
14
3 years 6.26
Extreme 6.26
16.01
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 19/08/2024
Director of Finance/CFO 50 21/08/2019
Chief Tech/Sci/R&D Officer - 01/06/2025
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 21/08/2019
Director/Board Member 60 21/01/2022
Date Insider Type Main position Quantity % Market Cap. Importance
15/07/26 Buy

Chairman

50,006 0.0228%
13/06/25 Free 350,000 0.3777%
13/06/25 Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
+6.45%+3.12%-31.25%-46.77% 22.48M
-0.32%-5.97%+57.78%+74.48% 70.44B
+0.86%-13.50%+5.56%+54.34% 50.31B
+3.67%+1.46%+11.88%+37.43% 47.51B
-0.58%+0.27%+27.93%+30.76% 42.91B
-2.84%-5.72%+286.54%+530.02% 40.39B
-0.38%-3.78%+6.74%+95.25% 39.69B
-0.39%-1.48%+10.41%+43.19% 30.59B
-2.95%-12.28%+43.51%+1.51% 26.8B
-7.13%-7.02%-12.99%-14.07% 22.36B
Average -0.35%-5.39%+40.61%+80.61% 37.1B
Weighted average by Cap. -0.55%-5.61%+51.60%+100.57%

Financials

2026 *2027 *
Net sales 8M 10.6M 9.47M 8.82M 15.06M 1.01B 15.17M 106M 41.38M 523M 39.8M 38.93M 1.68B 9M 11.92M 10.65M 9.93M 16.94M 1.13B 17.07M 119M 46.55M 589M 44.78M 43.79M 1.89B
Net income -2.14M -2.84M -2.54M -2.36M -4.03M -269M -4.06M -28.32M -11.08M -140M -10.66M -10.43M -450M -2.8M -3.71M -3.31M -3.09M -5.27M -352M -5.31M -37.01M -14.49M -183M -13.94M -13.63M -588M
Net Debt -10.2M -13.51M -12.07M -11.25M -19.2M -1.28B -19.35M -135M -52.76M -667M -50.75M -49.63M -2.14B -6.1M -8.08M -7.22M -6.73M -11.48M -767M -11.57M -80.6M -31.55M -399M -30.35M -29.68M -1.28B
Projected Income Statement - Annual - IXICO plc
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
14/10/26 GBX 8.250 +6.45% 409
13/10/26 GBX 7.750 0.00% 42,414
12/10/26 GBX 7.750 0.00% 17,645
09/10/26 GBX 7.750 0.00% 8,415
08/10/26 GBX 7.750 -3.12% 7,685
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - IXICO plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0775GBP
Average target price
0.2600GBP
Spread / Average Target
+235.48%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - IXICO plc